Trademark Overview
On Thursday, September 11, 2025, a trademark application was filed for ACRIVON with the United States Patent and Trademark Office. The USPTO has given the ACRIVON trademark a serial number of 99388089. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, September 11, 2025. This trademark is owned by Acrivon Therapeutics, Inc.. The ACRIVON trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical preparations for the treatment and prevention of cancer, fibrotic, inflammatory, autoimmune, metabolic, infectious, central nervous system, or other diseases; Protein arrays for diagnosing cancer; Pharmaceutical preparations for the prediction of drug treatment efficacy; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; Reagents for medical purposes; Medical diagnostic reagents for use in drug-tailored efficacy predication and analysis; Diagnostic agents, preparations and substances for medical purposes; Diagnostic biomarker reagents for medical purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for medical purposes for detecting genetic predispositions; Biological preparations for the prevention and treatment of cancer, fibrotic, inflammatory, autoimmune, metabolic, infectious, central...
Medical services; Medical testing services; Medical diagnostic testing, monitoring and reporting services; Medical testing services relating to the diagnosis and treatment of disease; Medical testing for diagnostic or treatment purposes in the field of oncology, fibrotic, inflammatory, autoimmune, metabolic, infectious, central nervous system, or other diseases; Medical counseling; Providing medical information to medical professional in the form of reports in the field of oncology and precision medicine; Providing a website featuring information in the field of oncology, fibrotic, inflammatory, autoimmune, metabolic, infectious, central nervous system, or other diseases and precision medicine; health
Medical and scientific research in the field of oncology; Medical and scientific research in the field of proteomics, biomarker discovery, rational drug design in drug discovery, patient responder identification and indication finding, precision medicine clinical trials based on responder identification; Biochemical analysis services in the field of biomarker discovery; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research in the field of pharmaceuticals, therapeutics, and drug formulation and delivery; Scientific research in the field of proteomics and biomarker discovery; Consulting services in the field of pharmaceutical research and development; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields
